📊 Midday Market Take

Hey there, hope your Monday morning coffee is still warm because markets are giving us a mixed bag right now. The S&P 500 and Nasdaq are nudging higher, up 0.15% and 0.42% respectively, while the Dow is sliding 0.41% lower and dragging its feet.

Tech is clearly carrying the load today, with growth names pushing the Nasdaq ahead of its blue-chip counterparts. Keep an eye on whether that tech momentum holds into the final hours, because a fade there could pull the broader market back toward flat.

Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease.

3 Reasons to Watch COAG

• The Stock Nearly Doubled in 30 Days. COAG has surged 96.72% over the past month, making it one of the more eye-catching movers in biotech right now. That kind of momentum tends to attract attention, and with multiple clinical catalysts hitting at once, there's a clear reason behind the run.
• Pipeline Data Just Hit a Major Medical Stage. Hemab presented clinical and preclinical data from its lead drug sutacimig in both Glanzmann thrombasthenia and Factor VII deficiency at the ISTH 2026 Congress this week. Showing data at a top-tier hematology conference is exactly the kind of visibility event that puts a small clinical-stage company on institutional radar.
• A Third Asset Just Entered the Picture. Beyond its two existing clinical programs, Hemab introduced HMB-003 at ISTH 2026, a new candidate targeting heavy menstrual bleeding, alongside fresh data from HMB-002 in Von Willebrand disease. Expanding a pipeline while your existing drugs are still in active development signals the company is building toward a multi-indication franchise, not just a one-drug story.

Top Market Headlines

SK Hynix, AST SpaceMobile, SpaceX: 5 Stocks Investors Couldn't Stop Buzzing About This Week

Retail investors talked up five hot stocks during the week (July 13 to July 17) on X and Reddit's r/WallStreetBets, driven by retail hype, earnings...

AI bubble to POP July 29th (Ad)

He predicted the 2008 financial crisis... He predicted Trump's election in 2016... He even predicted the rise of COVID-19 writing: "The chance we don't have something on the scale of a national pandemic in the next few years is near zero" That was three months before the first reported case. If he's right again, God Bless America... Because this crisis will be tectonic in scale...and it's going to begin with the bubble popping in AI.

Jim Cramer Says the Market Is “Dead Wrong” About These 5 Oversold Stocks

On Thursday, July 16, during the broadcast of Mad Money , Jim Cramer pushed back on the market's punishment of several blue-chip companies that jus...

Chevron & 2 Energy Stocks Poised to Beat Q2 Earnings Estimates

CVX, BKR and WHD look poised to beat Q2 earnings estimates as high oil prices are likely to have supported production, drilling and oilfield servic...

2026 Is Already Setting the Stage — These 3 Names Caught Our Eye (Ad)

The biggest market opportunities don't wait for headlines — by the time the news breaks, the real move is often over. That's why we do the work early, and right now we're watching three small-cap companies that align with conditions historically preceding major market attention in 2026.

Best Momentum Stocks to Buy for July 20th

STT, AEHR and NBIS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 20, 2026.

The Energy Shock Is Here (Ad)

Tanker traffic through Hormuz has collapsed. LNG capacity is offline. Countries are already rationing fuel. Energy shocks don’t stay contained—they spread through the entire economy. As a market technician, I’ve studied these cycles for decades, and they always lead to monetary response—and currency pressure.

📈 Also Trending

It's one of Trump's biggest holdings. Do you own it? (Ad)

President Trump owns up to $5 million in shares of this AI company (not Nvidia or SpaceX). He's strongly endorsed its leadership and products. And he just awarded it with a nearly $10 billion Pentagon contract. No wonder one legendary fund manager says it could become the cornerstone of your retirem...

Click here for its name and ticker.

Elon Musk Just Said 8 Words That Should TERRIFY Every Investor on Wall Street (Ad)

"The cost of everything will drop to NOTHING." That's what Musk told a room full of stunned executives. Most people laughed. One man didn't. A 41-year stock market legend - the SAME man who bought Apple at $1... called NVIDIA at $1.10... both split adjusted says Musk is right. And he's identified a...

For the full story, click here.

Problems at SpaceX: time to get out? (Ad)

Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, C...

Learn how to prepare your portfolio for what's coming next